<table class="drug-table data-table table table-condensed table-bordered"><tbody><tr id="identification"><th class="divider" colspan="2">Identification</th></tr><tr><th>Name</th><td><strong>7,9-Dihydro-1h-Purine-2,6,8(3h)-Trione</strong></td></tr><tr><th>Accession Number</th><td><strong>DB01696</strong>&#160; (EXPT03202)</td></tr><tr><th>Type</th><td>small molecule</td></tr><tr><th>Groups</th><td>experimental</td></tr><tr><th>Description</th><td><span class="wishart wishart-not-available">Not Available</span></td></tr><tr><th>Structure</th><td><div class="structure"><a class="moldbi-thumbnail" href="http://structures.wishartlab.com/molecules/DB01696/image.png"><img alt="Thumb" src="http://structures.wishartlab.com/molecules/DB01696/thumb.png"></a></div><div class="structure-links"><div class="btn-group btn-group-xs"><a class="btn btn-default" href="/structures/structures/small_molecule_drugs/DB01696.mol">MOL</a><a class="btn btn-default" href="/structures/structures/small_molecule_drugs/DB01696.sdf">SDF</a><a class="btn btn-default" href="/structures/structures/small_molecule_drugs/DB01696.pdb">PDB</a><a class="btn btn-default" href="/structures/structures/small_molecule_drugs/DB01696.smiles">SMILES</a><a class="btn btn-default" href="/structures/structures/small_molecule_drugs/DB01696.inchi">InChI</a><a class="btn btn-info" href="/structures/structures/small_molecule_drugs/DB01696">View Structure</a></div></div></td></tr><tr><th>Synonyms</th><td><span class="wishart wishart-not-available">Not Available</span></td></tr><tr><th>Salts</th><td><span class="wishart wishart-not-available">Not Available</span></td></tr><tr><th>Brand names</th><td><span class="wishart wishart-not-available">Not Available</span></td></tr><tr><th>Brand mixtures</th><td><span class="wishart wishart-not-available">Not Available</span></td></tr><tr><th>Categories</th><td><span class="wishart wishart-not-available">Not Available</span></td></tr><tr><th>CAS number</th><td>69-93-2</td></tr><tr><th>Weight</th><td>Average: 168.1103<br>Monoisotopic: 168.028340014</td></tr><tr><th>Chemical Formula</th><td>C<sub>5</sub>H<sub>4</sub>N<sub>4</sub>O<sub>3</sub></td></tr><tr><th>InChI Key</th><td>LEHOTFFKMJEONL-UHFFFAOYSA-N</td></tr><tr><th>InChI</th><td><div class="wrap">InChI=1S/C5H4N4O3/c10-3-1-2(7-4(11)6-1)8-5(12)9-3/h(H4,6,7,8,9,10,11,12)</div></td></tr><tr><th>IUPAC Name</th><td><div class="wrap">2,3,6,7,8,9-hexahydro-1H-purine-2,6,8-trione</div></td></tr><tr><th>SMILES</th><td><div class="wrap">O=C1NC2=C(N1)C(=O)NC(=O)N2</div></td></tr><tr><th>Mass Spec</th><td><span class="wishart wishart-not-available">Not Available</span></td></tr><tr id="taxonomy"><th class="divider" colspan="2">Taxonomy</th></tr><tr><th>Kingdom</th><td>Organic Compounds</td></tr><tr><th>Superclass</th><td>Heterocyclic Compounds</td></tr><tr><th>Class</th><td>Imidazopyrimidines</td></tr><tr><th>Subclass</th><td>Purines and Purine Derivatives</td></tr><tr><th>Direct parent</th><td>Xanthines</td></tr><tr><th>Alternative parents</th><td>Purinones; Pyrimidones; Imidazoles; Polyamines</td></tr><tr><th>Substituents</th><td>pyrimidone; pyrimidine; imidazole; azole; polyamine; organonitrogen compound</td></tr><tr><th>Classification description</th><td>This compound belongs to the xanthines. These are purine derivatives with a ketone group conjugated at carbons 2 and 6 of the purine moiety.</td></tr><tr id="pharmacology"><th class="divider" colspan="2">Pharmacology</th></tr><tr><th>Indication</th><td><span class="wishart wishart-not-available">Not Available</span></td></tr><tr><th>Pharmacodynamics</th><td><span class="wishart wishart-not-available">Not Available</span></td></tr><tr><th>Mechanism of action</th><td><span class="wishart wishart-not-available">Not Available</span></td></tr><tr><th>Absorption</th><td><span class="wishart wishart-not-available">Not Available</span></td></tr><tr><th>Volume of distribution</th><td><span class="wishart wishart-not-available">Not Available</span></td></tr><tr><th>Protein binding</th><td><span class="wishart wishart-not-available">Not Available</span></td></tr><tr><th>Metabolism</th><td class="data-table-container"></td></tr><tr><th>Route of elimination</th><td><span class="wishart wishart-not-available">Not Available</span></td></tr><tr><th>Half life</th><td><span class="wishart wishart-not-available">Not Available</span></td></tr><tr><th>Clearance</th><td><span class="wishart wishart-not-available">Not Available</span></td></tr><tr><th>Toxicity</th><td><span class="wishart wishart-not-available">Not Available</span></td></tr><tr><th>Affected organisms</th><td><span class="wishart wishart-not-available">Not Available</span></td></tr><tr><th>Pathways</th><td class="data-table-container"><table class="table table-condensed table-striped" id="pathways"><thead><tr><th>Pathway</th><th>Category</th></tr></thead><tbody><tr><td>Thioguanine Action Pathway</td><td>Drug action</td></tr><tr><td>Azathioprine Action Pathway</td><td>Drug action</td><td><a class="btn btn-default btn-xs" href="http://www.smpdb.ca/view/SMP00427?highlight%5Bcompounds%5D%5B%5D=DB01696&amp;highlight%5Bproteins%5D%5B%5D=DB01696">SMP00427</a></td></tr><tr><td>Mercaptopurine Action Pathway</td><td>Drug action</td><td><a class="btn btn-default btn-xs" href="http://www.smpdb.ca/view/SMP00428?highlight%5Bcompounds%5D%5B%5D=DB01696&amp;highlight%5Bproteins%5D%5B%5D=DB01696">SMP00428</a></td></tr><tr><td>Adenine phosphoribosyltransferase deficiency (APRT)</td><td>Disease</td><td><a class="btn btn-default btn-xs" href="http://www.smpdb.ca/view/SMP00535?highlight%5Bcompounds%5D%5B%5D=DB01696&amp;highlight%5Bproteins%5D%5B%5D=DB01696">SMP00535</a></td></tr><tr><td>Adenosine Deaminase Deficiency</td><td>Disease</td><td><a class="btn btn-default btn-xs" href="http://www.smpdb.ca/view/SMP00144?highlight%5Bcompounds%5D%5B%5D=DB01696&amp;highlight%5Bproteins%5D%5B%5D=DB01696">SMP00144</a></td></tr><tr><td>Adenylosuccinate Lyase Deficiency</td><td>Disease</td><td><a class="btn btn-default btn-xs" href="http://www.smpdb.ca/view/SMP00167?highlight%5Bcompounds%5D%5B%5D=DB01696&amp;highlight%5Bproteins%5D%5B%5D=DB01696">SMP00167</a></td></tr><tr><td>AICA-Ribosiduria</td><td>Disease</td><td><a class="btn btn-default btn-xs" href="http://www.smpdb.ca/view/SMP00168?highlight%5Bcompounds%5D%5B%5D=DB01696&amp;highlight%5Bproteins%5D%5B%5D=DB01696">SMP00168</a></td></tr><tr><td>Molybdenium Cofactor Deficiency</td><td>Disease</td><td><a class="btn btn-default btn-xs" href="http://www.smpdb.ca/view/SMP00203?highlight%5Bcompounds%5D%5B%5D=DB01696&amp;highlight%5Bproteins%5D%5B%5D=DB01696">SMP00203</a></td></tr><tr><td>Myoadenylate deaminase deficiency</td><td>Disease</td><td><a class="btn btn-default btn-xs" href="http://www.smpdb.ca/view/SMP00537?highlight%5Bcompounds%5D%5B%5D=DB01696&amp;highlight%5Bproteins%5D%5B%5D=DB01696">SMP00537</a></td></tr><tr><td>Xanthine Dehydrogenase Deficiency (Xanthinuria)</td><td>Disease</td><td><a class="btn btn-default btn-xs" href="http://www.smpdb.ca/view/SMP00220?highlight%5Bcompounds%5D%5B%5D=DB01696&amp;highlight%5Bproteins%5D%5B%5D=DB01696">SMP00220</a></td></tr><tr><td>Purine Nucleoside Phosphorylase Deficiency</td><td>Disease</td><td><a class="btn btn-default btn-xs" href="http://www.smpdb.ca/view/SMP00210?highlight%5Bcompounds%5D%5B%5D=DB01696&amp;highlight%5Bproteins%5D%5B%5D=DB01696">SMP00210</a></td></tr><tr><td>Mitochondrial DNA depletion syndrome</td><td>Disease</td><td><a class="btn btn-default btn-xs" href="http://www.smpdb.ca/view/SMP00536?highlight%5Bcompounds%5D%5B%5D=DB01696&amp;highlight%5Bproteins%5D%5B%5D=DB01696">SMP00536</a></td></tr><tr><td>Gout or Kelley-Seegmiller Syndrome</td><td>Disease</td><td><a class="btn btn-default btn-xs" href="http://www.smpdb.ca/view/SMP00365?highlight%5Bcompounds%5D%5B%5D=DB01696&amp;highlight%5Bproteins%5D%5B%5D=DB01696">SMP00365</a></td></tr><tr><td>Xanthinuria type I</td><td>Disease</td><td><a class="btn btn-default btn-xs" href="http://www.smpdb.ca/view/SMP00512?highlight%5Bcompounds%5D%5B%5D=DB01696&amp;highlight%5Bproteins%5D%5B%5D=DB01696">SMP00512</a></td></tr><tr><td>Xanthinuria type II</td><td>Disease</td><td><a class="btn btn-default btn-xs" href="http://www.smpdb.ca/view/SMP00513?highlight%5Bcompounds%5D%5B%5D=DB01696&amp;highlight%5Bproteins%5D%5B%5D=DB01696">SMP00513</a></td></tr><tr><td>Lesch-Nyhan Syndrome (LNS)</td><td>Disease</td><td><a class="btn btn-default btn-xs" href="http://www.smpdb.ca/view/SMP00364?highlight%5Bcompounds%5D%5B%5D=DB01696&amp;highlight%5Bproteins%5D%5B%5D=DB01696">SMP00364</a></td></tr><tr><td>Purine Metabolism</td><td>Metabolic</td><td><a class="btn btn-default btn-xs" href="http://www.smpdb.ca/view/SMP00050?highlight%5Bcompounds%5D%5B%5D=DB01696&amp;highlight%5Bproteins%5D%5B%5D=DB01696">SMP00050</a></td></tr></tbody></table></td></tr><tr><th>SNP Mediated Effects</th><td><span class="wishart wishart-not-available">Not Available</span></td></tr><tr><th>SNP Mediated Adverse Drug Reactions</th><td><span class="wishart wishart-not-available">Not Available</span></td></tr><tr id="admet"><th class="divider" colspan="2">ADMET</th></tr><tr><th>Predicted ADMET features</th><td class="data-table-container"><table class="table table-condensed table-striped" id="predicted-admet">
  <thead>
    <tr>
      <th>Property</th>
      <th>Value</th>
      <th>Probability</th>
    </tr>
  </thead>
  <tbody>
      <tr>
        <td>Human Intestinal Absorption</td>
        <td>
              +
        </td>
        <td>0.9927</td>
      </tr>
      <tr>
        <td>Blood Brain Barrier</td>
        <td>
              +
        </td>
        <td>0.9731</td>
      </tr>
      <tr>
        <td>Caco-2 permeable</td>
        <td>
              -
        </td>
        <td>0.7844</td>
      </tr>
      <tr>
        <td>P-glycoprotein substrate</td>
        <td>
            Non-substrate
        </td>
        <td>0.5895</td>
      </tr>
      <tr>
        <td>P-glycoprotein inhibitor I</td>
        <td>
            Non-inhibitor
        </td>
        <td>0.9651</td>
      </tr>
      <tr>
        <td>P-glycoprotein inhibitor II</td>
        <td>
            Non-inhibitor
        </td>
        <td>0.9967</td>
      </tr>
      <tr>
        <td>Renal organic cation transporter</td>
        <td>
            Non-inhibitor
        </td>
        <td>0.9391</td>
      </tr>
      <tr>
        <td>CYP450 2C9 substrate</td>
        <td>Non-substrate</td>
        <td>0.7785</td>
      </tr>
      <tr>
        <td>CYP450 2D6 substrate</td>
        <td>Non-substrate</td>
        <td>0.7666</td>
      </tr>
      <tr>
        <td>CYP450 3A4 substrate</td>
        <td>Non-substrate</td>
        <td>0.7568</td>
      </tr>
      <tr>
        <td>CYP450 1A2 substrate</td>
        <td>Non-inhibitor</td>
        <td>0.5</td>
      </tr>
      <tr>
        <td>CYP450 2C9 substrate</td>
        <td>Non-inhibitor</td>
        <td>0.8924</td>
      </tr>
      <tr>
        <td>CYP450 2D6 substrate</td>
        <td>Non-inhibitor</td>
        <td>0.9124</td>
      </tr>
      <tr>
        <td>CYP450 2C19 substrate</td>
        <td>Non-inhibitor</td>
        <td>0.8894</td>
      </tr>
      <tr>
        <td>CYP450 3A4 substrate</td>
        <td>Non-inhibitor</td>
        <td>0.8512</td>
      </tr>
      <tr>
        <td>CYP450 inhibitory promiscuity</td>
        <td>Low CYP Inhibitory Promiscuity</td>
        <td>0.993</td>
      </tr>
      <tr>
        <td>Ames test</td>
        <td>
          Non AMES toxic 
        </td>
        <td>
            0.8148
        </td>
      </tr>
      <tr>
        <td>Carcinogenicity</td>
        <td>
          Non-carcinogens 
        </td>
        <td>
            0.9508
        </td>
      </tr>
      <tr>
        <td>Biodegradation</td>
        <td>
          Not ready biodegradable 
        </td>
        <td>
            0.56
        </td>
      </tr>
      <tr>
        <td>Rat acute toxicity</td>
        <td>
          2.0522 
            LD50, mol/kg
        </td>
        <td>
            <span class="wishart wishart-not-available">Not applicable</span>
        </td>
      </tr>
      <tr>
        <td>hERG inhibition (predictor I)</td>
        <td>
          Weak inhibitor 
        </td>
        <td>
            0.9564
        </td>
      </tr>
      <tr>
        <td>hERG inhibition (predictor II)</td>
        <td>
          Non-inhibitor 
        </td>
        <td>
            0.9563
        </td>
      </tr>
  </tbody>
</table>
</td></tr><tr id="pharmacoeconomics"><th class="divider" colspan="2">Pharmacoeconomics</th></tr><tr><th>Manufacturers</th><td><span class="wishart wishart-not-available">Not Available</span></td></tr><tr><th>Packagers</th><td><span class="wishart wishart-not-available">Not Available</span></td></tr><tr><th>Dosage forms</th><td><span class="wishart wishart-not-available">Not Available</span></td></tr><tr id="spectra"><th class="divider" colspan="2">Spectra</th></tr><tr><th>Spectra</th><td><ul><li><a data-no-turbolink="true" href="/spectra/spectra/c_ms/48">Gas-MS Spectrum</a></li>
<li><a data-no-turbolink="true" href="/spectra/spectra/ms_ms/489">MS/MS Spectrum Quattro_QQQ 10</a></li>
<li><a data-no-turbolink="true" href="/spectra/spectra/ms_ms/490">MS/MS Spectrum Quattro_QQQ 25</a></li>
<li><a data-no-turbolink="true" href="/spectra/spectra/ms_ms/491">MS/MS Spectrum Quattro_QQQ 40</a></li>
<li><a data-no-turbolink="true" href="/spectra/spectra/ms_ms/3928">MS/MS Spectrum GC-EI-TOF (Pegasus III TOF-MS system, Leco; GC 6890, Agilent Technologies	) </a></li>
<li><a data-no-turbolink="true" href="/spectra/spectra/ms_ms/7412">MS/MS Spectrum GC-MS </a></li>
<li><a data-no-turbolink="true" href="/spectra/spectra/ms_ms/7441">MS/MS Spectrum GC-MS </a></li></ul></td></tr><tr id="interactions"><th class="divider" colspan="2">Interactions</th></tr><tr><th>Drug Interactions</th><td><span class="wishart wishart-not-available">Not Available</span></td></tr><tr><th>Food Interactions</th><td><span class="wishart wishart-not-available">Not Available</span></td></tr></tbody></table>